NL-OMON24957
Completed
Not Applicable
Attention Bias Modification Training for Major Depressive Disorder: A Randomized Controlled Trial
Pro Persona, Center for Mental Health Care, Nijmegen, The NetherlandsWolfheze 2, 6874 Wolfheze0 sites126 target enrollmentTBD
ConditionsMajor Depressive Disorder (MDD)
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Major Depressive Disorder (MDD)
- Sponsor
- Pro Persona, Center for Mental Health Care, Nijmegen, The NetherlandsWolfheze 2, 6874 Wolfheze
- Enrollment
- 126
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •A diagnosis of major depressive disorder, first or recurrent according to the DSM\- IV\-TR, as assessed with the MINI Neuropsychiatric Interview
- •Age: between 18\-65 years
Exclusion Criteria
- •Any psychotic disorder (current or previous)
- •Current mania or hypomania or a history of bipolar disorder
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Study to compare the safety and efficacy of Omadacycline versus Levofloxacin for adults with acute pyelonephritisAcute PyelonephritisMedDRA version: 20.1Level: LLTClassification code 10001032Term: Acute pyelonephritisSystem Organ Class: 100000004862Therapeutic area: Diseases [C] - Bacterial Infections and Mycoses [C01]EUCTR2018-000037-13-LVParatek Pharma, LLC, a wholly-owned subsidiary of Paratek Pharmaceuticals, Inc.200
Unknown
Phase 2
Safety, Pharmacokinetics, Pharmacodynamics and Efficacy study of MRG-001 on Severe and Critical SARS-CoV-2CTRI/2022/01/039274Medregen LLC
Recruiting
Phase 2
Investigating Novel Pharmacological Treatments for Anorexia Nervosa - A Clinical TrialAnorexia nervosaMental Health - Eating disordersACTRN12623001019695Monash University100
Active, not recruiting
Phase 1
Therapeutics for Inpatients with COVID-19 (TICO)EUCTR2020-003278-37-GBReagents of the University of Minnesota1,000
Active, not recruiting
Phase 1
Therapeutics for Inpatients with COVID-19 (TICO)Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)MedDRA version: 23.0Level: PTClassification code 10051905Term: Coronavirus infectionSystem Organ Class: 10021881 - Infections and infestationsTherapeutic area: Diseases [C] - Virus Diseases [C02]EUCTR2020-003278-37-ITIVERSITY COLLEGE LONDO2,000